SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 000-18728

 

 

 

Endo Pharmaceuticals Solutions Inc.

(Exact name of registrant as specified in its charter)

 

 

100 Endo Boulevard

Chadds Ford, Pennsylvania 19317

Telephone: (610) 558-9800

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

 

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		x
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		x
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Endo Pharmaceuticals Solutions Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

						Endo Pharmaceuticals Solutions Inc.
Date:		April 2, 2009				By:		/S/ CAROLINE B. MANOGUE
								Name: Caroline B. Manogue
								Title:   Executive Vice President,
								Chief Legal Officer and Secretary